News – Page 430 – Endpoints News

Emergent scores a DoD award to evaluate its chikungunya vaccine in the field

3 years ago

Tenaya bags $75M from stock sale as it prepares to put a gene therapy for heart disease into the clinic

3 years ago

Regeneron throws struggling CytomX a lifeline with $30M cancer bispecific deal

3 years ago

GSK's cell therapy retreat hits another partner as drugmaker exits Immatics collaboration

3 years ago

Gunning for first chikungunya vaccine OK, Valneva raids GSK for a seasoned commercial chief

3 years ago

Astellas spotlights PFS, OS win for CLDN18.2 — six years after buying BioNTech founders' other company for $1.4B

3 years ago

Updated: In surprise turn, FDA adcomm votes in favor of Ardelyx CKD drug despite agency questions

3 years ago

Novartis considers selling its $5B+ ophthalmology and respiratory units — report

3 years ago

More than 150 industry groups urge Congress to act on antimicrobial resistance

3 years ago

Merck KGaA’s MilliporeSigma invests $286M to build out biosafety testing

3 years ago

Top PBM to put Humira biosimilars on level playing field with AbbVie blockbuster

3 years ago

UK cost watchdog drafts guidance against 5 Covid treatments and J&J depression med

3 years ago

Ecommerce marketing for pharma? Agency adds new specialty unit with eye to future

3 years ago

Biden looks for $9B+ in new Covid funds as Senate passes resolution to end emergency declaration

3 years ago

Kriya acquires gene therapy startup for undisclosed sum; Compugen wins milestone payment from AstraZeneca

3 years ago

Scorpion Capital goes after Twist Bioscience as latest synbio target, comparing biotech to Theranos

3 years ago

Illumina becomes the latest domino in layoffs trend, cutting around 5% of its workforce

3 years ago

For $30M, Chinese biopharma Simcere picks up regional rights to Idorsia’s insomnia drug

3 years ago

Following ASCO showing, Bert Vogelstein’s latest startup launches into recurrent cancer detection

3 years ago

Months removed from a $118M Series B, Mineralys pushes ahead with PhII hypertension data

3 years ago

First came the news of strategic review. Now Tricida is letting more than half of its staff go in wake of PhIII flop

3 years ago

Updated: Picking up the pieces after lead drug imploded, Rafael Holdings gives up on early R&D in favor of deals

3 years ago

In a step toward shorter tuberculosis treatment, GSK reports positive mid-stage data for antibiotic

3 years ago

Drugmaker fined by Spanish regulators $10M for 'excessive price' of rare disease drug

3 years ago

First page Previous page 427 428 429430431 432 433 Next page Last page